We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.71B
AUM Growth
+$182M
Cap. Flow
-$102M
Cap. Flow %
-1.32%
Top 10 Hldgs %
27.14%
Holding
420
New
12
Increased
175
Reduced
164
Closed
17

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$73.9M
2
MDT icon
Medtronic
MDT
+$52.6M
3
TFC icon
Truist Financial
TFC
+$30.9M
4
JNJ icon
Johnson & Johnson
JNJ
+$11.1M
5
HON icon
Honeywell
HON
+$10.3M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$66.7M
2
SJM icon
J.M. Smucker
SJM
+$57.4M
3
KMB icon
Kimberly-Clark
KMB
+$35.4M
4
NVS icon
Novartis
NVS
+$19.8M
5
WEC icon
WEC Energy
WEC
+$5.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.9%
2 Healthcare 15.69%
3 Technology 15.19%
4 Financials 12.45%
5 Industrials 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOX icon
251
Amdocs
DOX
$5.91B
$801K 0.01%
13,883
+690
+5% +$39.6K
LHX icon
252
L3Harris
LHX
$52.6B
$800K 0.01%
9,590
+715
+8% +$56.5K
PII icon
253
Polaris
PII
$4.12B
$794K 0.01%
9,710
+3,867
+66% +$343K
TPL icon
254
Texas Pacific Land
TPL
$28B
$793K 0.01%
42,300
-900
-2% -$16K
GLD icon
255
SPDR Gold Trust
GLD
$132B
$785K 0.01%
6,207
+17
+0.3% +$2.05K
GSK icon
256
GSK
GSK
$103B
$784K 0.01%
14,477
-1,658
-10% -$87.3K
CRUS icon
257
Cirrus Logic
CRUS
$6.63B
$768K 0.01%
+19,800
New +$710K
TUP
258
DELISTED
Tupperware Brands Corporation
TUP
$767K 0.01%
13,625
+1,005
+8% +$57.4K
SNN icon
259
Smith & Nephew
SNN
$12.8B
$764K 0.01%
22,260
+5,275
+31% +$178K
SU icon
260
Suncor Energy
SU
$76.6B
$761K 0.01%
27,455
-704
-3% -$19.3K
HDB icon
261
HDFC Bank
HDB
$123B
$760K 0.01%
45,840
-104
-0.2% -$1.66K
EXR icon
262
Extra Space Storage
EXR
$31.4B
$757K 0.01%
8,181
+220
+3% +$19.9K
RMAX icon
263
RE/MAX Holdings
RMAX
$203M
$754K 0.01%
18,720
+1,275
+7% +$49K
NATI
264
DELISTED
National Instruments Corp
NATI
$726K 0.01%
26,519
+1,840
+7% +$51.3K
GK
265
DELISTED
G&K Services Inc
GK
$726K 0.01%
9,485
+725
+8% +$53.4K
RTN
266
DELISTED
Raytheon Company
RTN
$723K 0.01%
5,315
+71
+1% +$9.25K
NTRS icon
267
Northern Trust
NTRS
$33.6B
$718K 0.01%
10,831
HAL icon
268
Halliburton
HAL
$26.9B
$683K 0.01%
15,094
-80
-0.5% -$3.29K
TMO icon
269
Thermo Fisher Scientific
TMO
$209B
$681K 0.01%
4,610
-72
-2% -$10.6K
SI
270
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$678K 0.01%
6,604
+4,159
+170% +$427K
SAP icon
271
SAP
SAP
$223B
$677K 0.01%
9,013
+42
+0.5% +$3.3K
LEG icon
272
Leggett & Platt
LEG
$1.39B
$674K 0.01%
13,180
+1,055
+9% +$52K
MATV icon
273
Mativ Holdings
MATV
$501M
$661K 0.01%
18,745
+1,590
+9% +$53.6K
PEGA icon
274
Pegasystems
PEGA
$5.18B
$660K 0.01%
49,038
+3,440
+8% +$45.3K
POWI icon
275
Power Integrations
POWI
$3.49B
$660K 0.01%
26,372
+1,814
+7% +$44.3K

Similar funds

Bahl & Gaynor's Q2 2016 Portfolio in Review

As of Q2 2016, Bahl & Gaynor held 420 positions worth $7.71B, up 2.4% from $7.53B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q2 2016 filing shows 12 new, 175 increased, 164 reduced and 17 closed positions. Its largest new stake was Simpson Manufacturing: 23,694 shares worth $947K. The largest sale was Analog Devices, an estimated $66.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Bahl & Gaynor's largest Q2 2016 buy was Simpson Manufacturing: 23,694 shares worth $947K.
  • Bahl & Gaynor added most to Texas Instruments in Q2 2016, an estimated $73.9M increase.
  • Bahl & Gaynor's biggest Q2 2016 reduction was Analog Devices, cutting an estimated $66.7M.
  • Bahl & Gaynor fully exited Airgas Inc in Q2 2016, selling an estimated $3.17M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $7.71B portfolio in Q2 2016.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2016.
  • Bahl & Gaynor's portfolio value rose 2.4% quarter-over-quarter to $7.71B.

Based on Bahl & Gaynor's 13F filing for Q2 2016, filed 10 Aug 2016.